NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches

Go back to NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
(NASDAQ: NTHI) Delayed: 2.90 --0 (-0%)
Previous Close $2.90    52 Week High $ 
Open $2.90    52 Week Low $ 
Day High $2.90    P/E N/A 
Day Low $2.90    EPS $ 
Volume 6,408